The RIQAS HIV/Hepatitis EQA programme is designed to monitor the performance of tests used to detect HIV/Hepatitis virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for qualitative methods of analysis.

• Liquid ready-to-use
• 100% human plasma
• Quarterly reporting (5 samples per quarterly distribution)
• Submit results and view reports online via RIQASNet
• Suitable for qualitative methods of analysis only

Parameters

• Anti-HIV-1
• Anti-HIV-2
• Anti-HIV-1&2 (combined)
• Anti-HCV
• Anti-HBc
• Anti-HTLV-I
• Anti-HTLV-II
• Anti-HTLV-1&2 (combined)
• Anti-CMV
• HBsAg